hereditary spherocytosis - screening (eosin-5'-maleimide (EMA) staining) Referred Test

Back to the list
Eurofins Biomnis code

EMA

Synonyms
  • Minkowski - Chauffard disease
  • [To be translated]
Specialty

Haematology

Clinical significance

Hereditary spherocytosis, or Minkowski-Chauffard syndrome, is a form of congenital chronic haemolytic anaemia resulting from abnormalities in proteins in the red blood cell membrane. Flow cytometry by marking with eosin-5'-maleimide (EMA) of transmembrane proteins is n improved replacement for the osmotic fragility test to diagnose hereditary spherocytosis. It sensitivity is > 90% and its specificity is 89¿99% according to studies.

Preanalytics
  • A tube specifically for this analysis : No
Further information

ALWAYS attach the specific clinical information form (R39-INTGB :EMA)
The test must be performed within 72 hours after blood draw

Documents to download
Methodology

Flow Cytometry

Turnaround time

30 days

Testing Laboratory

Refered Test

Contact(s)
Customer Care
Caption

Referred TestThe pre-analytical conditions and prices are defined on the basis of the requirements of the performing laboratory.